AXICABTAGENE CILOLEUCEL (AXI-CEL; KTE-C19) IN PATIENTS WITH REFRACTORY AGGRESSIVE NON-HODGKIN LYMPHOMAS (NHL): PRIMARY RESULTS OF THE PIVOTAL TRIAL ZUMA-1 来自 学术范 喜欢 0 阅读量: 130 作者: SS Neelapu,FL Locke,NL Bartlett,LJ Lekakis,D Miklos,CA Jacobson,I Braunschweig,O Oluwole,T ...
Zuma Trialcould Bogdown Inadjournments and AppealsBYLINE: Jeremy GordinCape Times (South Africa)
et's Face It Now]]>Cape Times (South Africa)
Interventions In each trial, patients were randomly assigned (3:1:1) to 150 mg of risankizumab, 45 mg or 90 mg of ustekinumab (weight-based per label) for 52 weeks, or matching placebo for 16 weeks followed by risankizumab. Main Outcomes and Measures Integrated data from 2 trials were...
THE CASE OF S V ZUMA: Implications of allowing evidence of sexual history in rape trials Rape is one of the most underreported crimes worldwide, not least because of the trauma facing complainants once the case goes to trial. The case of S v Zu... Jake,Moloi - 《South African Crime ...
This randomized clinical trial demonstrates the efficacy of 2 different dosages of galcanezumab compared with placebo in the prevention of episodic
The first interim analysis of the phase 3 trial (DRAGON IV/CAP 05) of apatinib, camrelizumab, and chemotherapy as perioperative treatment for gastric cancer revealed a significant improvement in the primary endpoint of pathological complete response.26 Drawing upon these encouraging results, camre...
TN10替利珠单抗/Teplizumab预防T1DM的研究,由TrialNet实施,包括T1DM患者的76名亲属,他们的多种自身抗体呈阳性,且糖耐量异常。参与者被随机分配到替利珠单抗/Teplizumab(n = 44)或安慰剂(n = 32)静脉注射,疗程为14天。2019年...
In summary, this is the first clinical trial of any type targeting ROR1. The results support further development of cirmtuzumab as a specific and safe inhibitor of ROR1/Wnt5a signaling. The safety profile of cirmtuzumab makes it an ideal agent to combine with other therapies. We previously...
#1021 A phase 3 randomized controlled trial of ravulizumab in adult patients with IgA nephropathy BACKGROUND AND AIMS. The pathogenesis of IgA nephropathy (IgAN) includes the deposition of immune complexes in the kidney and activation of the complement ... T Hernán,B Jonathan,HH Lambers,......